Showing 51-60 of 3001 results for "".
MS Minute: Ibudilast
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-ibudilast/31622/Ibudilast is a phosphodiesterase inhibitor that has shown some benefit for progressive multiple sclerosis in a phase 2 trial.Approaches to MS Care in Later Life: Distinguishing Aging from Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/approaches-to-ms-care-in-later-life/37227/Distinguishing Aging from DiseaseACTRIMS 2016 Forum Coverage: Updates in MS Therapeutics and Research
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/actrims-2016-forum-coverage-updates-in-ms-therapeutics-and-research/30481/MS Minute: Menopause and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minutebrmenopause-and-multiple-sclerosis/32119/Multiple sclerosis and menopause have overlapping symptoms, complicating evaluation of disease progression and care of this population.MS THERAPY FOCUS SHIFTS TO ORAL COMPOUNDS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0509_news02-php/30927/Delayed MS Drugs Awaits Decision at FDA
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/delayed-ms-drugs-awaits-decision-at-fda/30657/Tysabri and MS: Putting the Odds in the Patient's Favor
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/tysabri-and-ms-putting-the-odds-in-the-patients-favor/30762/A recent analysis has created a better profile of who can receive Tysabri and when.Choosing an MS Treatment for the Individual Patient
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/choosing-an-ms-treatment-for-the-individual-patient/31983/Brain Health in MS: A Comprehensive Approach
https://practicalneurology.com/programs/cme/brain-health-in-ms-a-comprehensive-approach/32233/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Imaging Biomarkers: MS Progression in Focus
https://practicalneurology.com/programs/cme/imaging-biomarkers-ms-progression-in-focus/32230/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.